[
    {
        "file_name": "EmeraldHealthBioceuticalsInc_20200218_1-A_EX1A-6 MAT CTRCT_11987205_EX1A-6 MAT CTRCT_Development Agreement.txt",
        "perturbation": [
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "2.1 EHS and EHN shall bear all costs associated with the development, inventory, sales, and marketing of any product (\"Products\") which EHS or EHN sells.",
                "changed_text": "2.1 EHS and EHN shall bear all costs associated with the development, inventory, sales, and marketing of any product (\"Items\") which EHS or EHN sells.",
                "explanation": "The term \"Products\" is now interchanged with \"Items\" in this section without a clear definition. It's unclear if \"Items\" refers to the same things as \"Products\", leading to uncertainty about what costs EHS and EHN are responsible for.",
                "location": "ARTICLE 2 -- RESPONSIBILITIES, 2.1"
            },
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "5.3 Royalty/Commission Payments. Dr. Murray will receive an annual royalty on net sales (defined as gross sales minus returns) for any products (the \"Dr. Murray Products\") developed by Dr. Murray for EHN for as long as the Dr. Murray Products are being sold. The Dr. Murray Products will be listed on Schedule A attached hereto as they are developed and added to product portfolio.",
                "changed_text": "5.3 Royalty/Commission Payments. Dr. Murray will receive an annual royalty on net sales (defined as gross sales minus returns) for any goods (the \"Dr. Murray Goods\") developed by Dr. Murray for EHN for as long as the Dr. Murray Goods are being sold. The Dr. Murray Products will be listed on Schedule A attached hereto as they are developed and added to product portfolio.",
                "explanation": "The text now uses “Dr. Murray Goods” in place of “Dr. Murray Products.” This creates confusion as Schedule A references “Dr. Murray Products,” which is defined as referring to products, creating an internal contradiction.",
                "location": "ARTICLE 5 -- COMPENSATION, 5.3"
            },
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "All notices shall be given to the parties at the following addresses, or such other addresses as may be the subject of a notice given hereunder:",
                "changed_text": "All notifications shall be given to the parties at the following addresses, or such other addresses as may be the subject of a notice given hereunder:",
                "explanation": "The term 'notices' is replaced with 'notifications'. Without a clear definition clarifying that these terms are the same, it may lead to disputes on whether all requirements applying to 'notices' also apply to 'notifications.'",
                "location": "ARTICLE 8 -- NOTICES"
            }
        ]
    }
]